Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Pertussis toxin modulates microglia and T cell profile to protect experimental autoimmune encephalomyelitis.
Linkage of multiple sclerosis and guillain-barre syndrome: a population-based survey in isfahan, iran.
Is anemia a probable cause of fatigue in patients with multiple sclerosis?
Work productivity in relapsing multiple sclerosis: associations with disability, depression, fatigue, anxiety, cognition, and health-related quality of life.
Surgical Outcomes of Trigeminal Neuralgia in Patients with Multiple Sclerosis.
Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis optica.
The experimental autoimmune encephalomyelitis disease course is modulated by nicotine and other cigarette smoke components.
Consensus Recommendations for the Diagnosis and Treatment of Multiple Sclerosis The Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis (MENACTRIMS).
IL-17-induced MiR-873 attributes to the pathogenesis of experimental autoimmune encephalomyelitis by targeting A20 ubiquitin editing enzyme.
Positive Effect on Multiple Sclerosis With Treatment of Metabolic Syndrome.
The effect of ribavirin on reactive astrogliosis in experimental autoimmune encephalomyelitis.
The genetics of multiple sclerosis: review of current and emerging candidates.
Factors associated with poor sleep quality in patients with multiple sclerosis differ by disease duration.
Early versus delayed treatment with laquinimod demonstrated significant reduction in risk of disability progression – Results of three-year ALLEGRO study in relapsing-remitting multiple sclerosis
Central nervous system myeloid cells as drug targets: current status and translational challenges.
Voiding dysfunction in patients with neuromyelitis optica spectrum disorders.
Cognitive impairment in patients with multiple sclerosis predicts worse caregiver's health-related quality of life.
Does jcv antibody positivity encourage cessation of natalizumab therapy in multiple sclerosis?
From depression to neurodegeneration and heart failure: re-examining the potential of MAO inhibitors.
Targeting CXCL13 During Neuroinflammation.
Quantitative assessment of upper limb motor function in Multiple Sclerosis using an instrumented Action Research Arm Test.
Age of Onset as a Moderator of Cognitive Decline in Pediatric-Onset Multiple Sclerosis.
Lack of association between AQP4 polymorphisms and risk of inflammatory demyelinating disease in a Korean population.
How can we exploit the brain's ability to repair itself?
Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation.

Pages